Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2009
06/18/2009US20090155768 Reporter plasmid phage packaging system for detection of bacteria
06/18/2009US20090155418 ABFB-1 Gene of Penicillium Funiculosum
06/18/2009US20090155413 Enzyme
06/18/2009US20090155411 Metabolically engineered lactic acid bacteria and their use
06/18/2009US20090155350 Chlamydia antigens and protein vaccine
06/18/2009US20090155304 Modified Cyanovirin-N Polypeptide
06/18/2009US20090155303 Cpg single strand deoxynucleotides for use as adjuvant
06/18/2009US20090155302 Antigen Arrays for Treatment of Allergic Eosinophilic Diseases
06/18/2009US20090155301 Pseudoinfectious flavivirus and uses thereof
06/18/2009US20090155298 Matrix Metalloproteinase 11 Vaccine
06/18/2009US20090155297 Methods and Compositions for Inducing an Immune Response Against Multiple Antigens
06/18/2009US20090155296 based on a native version of the enzyme from E. corrodens and induces production of antibodies that inhibit the activity of the lysine decarboxylase enzyme in the oral cavity; comprising a substitution at a position corresponding to position 365 of SEQ ID NO:2
06/18/2009US20090155295 Vaccine
06/18/2009US20090155290 Antigen
06/18/2009US20090155283 Noncompetitive Domain Antibody Formats That Bind Interleukin 1 Receptor Type 1
06/18/2009US20090155276 NOVEL DKKL-1 Splice Product Modulators for Cancer Diagnosis and Therapy
06/18/2009US20090155271 pro-inflammatory cytokines, interleukins (IL-17A, IL-17F)
06/18/2009US20090155269 Mesothelin antibody protein fusions and methods of use
06/18/2009US20090155268 Growth Factor Binding Constructs Materials and Methods
06/18/2009US20090155264 Novel composition and methods for the treatment of psoriasis
06/18/2009US20090155263 Compositions and methods for the treatment of immune related diseases
06/18/2009US20090155257 Immunoglobulin variants and uses thereof
06/18/2009US20090155255 Cd23 binding molecules and methods of use thereof
06/18/2009US20090155253 Anti-cd20 antibodies and fusion proteins therof and methods of use
06/18/2009US20090155252 Using vascular endothelial growth factor-D (VEGF-D) specific immunoglobulin for treatment and prevention of cell proliferative and tumor disorders
06/18/2009US20090155251 Polypeptide compounds for inhibiting angiogenesis and tumor growth
06/18/2009US20090155250 Monoclonal antibodies against orthopoxviruses
06/18/2009US20090155249 Humanized antibody igg1
06/18/2009US20090155242 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response
06/18/2009US20090155239 Novel Protease, Microorganism Producing the Same, and Application Thereof
06/18/2009US20090155238 Xylanases, nucleic acids encoding them and methods for making and using them
06/18/2009US20090155232 Neonatal human hepatocytes immortalized using tert and methods of their use
06/18/2009US20090155222 Cell culture
06/18/2009US20090155213 Lactobacillus acidophilus nucleic acids and uses thereof
06/18/2009US20090155208 Methods and agents for modulating an immune response
06/18/2009US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa
06/18/2009US20090155174 RNA Interference Mediating Small RNA Molecules
06/18/2009US20090155165 Anti-igf-i receptor antibody
06/18/2009US20090155164 Human c-fms antigen binding proteins
06/18/2009US20090152116 Electrophoretic analysis of molecules using immobilized probes
06/18/2009US20090151600 Adhesive protein extracted from Mytilus galloprovincialis, Mytilus galloprovincialis foot protein-5; can be used as medical adhesives as they are non-toxic to the human body and do not impose immunogenicity; water-resistant bioadhesives
06/18/2009DE102007059891A1 C-terminale lfapsoriasinfragmente als antimikrobielle Peptide, deren Herstellung und Verwendung C-terminal lfapsoriasinfragmente as antimicrobial peptides, their preparation and use
06/18/2009CA2709153A1 Impaired wound healing compositions and treatments
06/18/2009CA2709107A1 Compositions and methods for producing isoprene
06/18/2009CA2708776A1 Methods for sequential replacement of targeted region by homologous recombination
06/18/2009CA2708766A1 Compositions and methods related to mrna translational enhancer elements
06/18/2009CA2708719A1 High-density lipoprotein-like peptide-phospholipid scaffold ("hpps") nanoparticles
06/18/2009CA2708354A1 Means for delivery of nucleic acids active for gene silencing using synthetic polymers
06/18/2009CA2708343A1 Method for increasing immunoreactivity
06/18/2009CA2708268A1 Polypeptides having feruloyl esterase activity and polynucleotides encoding same
06/18/2009CA2708108A1 Hydrogenase polypeptide and methods of use
06/18/2009CA2707979A1 Polypeptides modified by protein trans-splicing technology
06/18/2009CA2707732A1 Method of generating .rho.0 cells
06/18/2009CA2707042A1 Compositions and methods for inhibiting expression of factor vii gene
06/17/2009EP2071042A1 DNA Diagnostics based on mass spectrometry
06/17/2009EP2071040A2 Diagnostics and therapeutics for vascular disease
06/17/2009EP2071037A1 Vessel for blood sampling
06/17/2009EP2071036A2 Methods for identifying RNA-binding compounds
06/17/2009EP2071030A2 Oligoribonucleotide or peptide nucleic acid which inhibits action of hepatitis C virus
06/17/2009EP2071029A2 Method for treating a sample that contains biomolecules
06/17/2009EP2071028A2 HLA-DR-binding antigen peptide derived from WT1
06/17/2009EP2071027A1 Method of generating Rho° cells
06/17/2009EP2071026A1 Nucleic acid detection cassette and nucleic acid detection apparatus
06/17/2009EP2071025A1 Primer set for amplification of ugt1a1 gene, reagent for amplification of ugt1a1 gene comprising the same, and use of the same
06/17/2009EP2071023A2 Novel enzyme
06/17/2009EP2071022A1 S-adenosylmethionine synthetase mutants, the dnas encoding the same and uses of the mutants
06/17/2009EP2070970A2 Transfection Reagent
06/17/2009EP2070949A2 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
06/17/2009EP2070948A1 Humanized Anti-CD4 antibody with immunosuppressive properties
06/17/2009EP2070947A1 Therapeutic and diagnostic anti-Hsp70 antibodies
06/17/2009EP2070945A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae
06/17/2009EP2070944A1 Specific binding agents of human angiopoietin-2
06/17/2009EP2070939A1 Modulators of pharmacological agents
06/17/2009EP2070548A1 Diagnosis and treatment of cancer using anti-ereg antibody
06/17/2009EP2070546A1 Preventives/remedies for cancer
06/17/2009EP2070542A2 Method of extended culture of antigen-specific cyotoxic T lymphocytes
06/17/2009EP2069511A2 System, method, and device for the expression or repression of proteins
06/17/2009EP2069510A2 Methods for rapidly transforming monocots
06/17/2009EP2069509A2 Plants having enhanced yield-related traits and a method for making the same
06/17/2009EP2069508A2 Plants having enhanced yield-related traits and a method for making the same
06/17/2009EP2069507A2 Plants having enhanced yield-related traits and/or increased abiotic stress resistance, and a method for making the same
06/17/2009EP2069506A2 Maize event dp-098140-6 and compositions and methods for the identification and/or detection thereof
06/17/2009EP2069505A2 Plants having enhanced yield-related traits and a method for method for making the same
06/17/2009EP2069504A1 Plants having enhanced seed yield-related traits and a method for making the same
06/17/2009EP2069503A1 Papaya mosaic virus-based vaccines for influenza
06/17/2009EP2069502A1 Method for making maturated insulin polypeptides
06/17/2009EP2069501A2 Rna interference against wrap53 to treat hyperproliferative diseases
06/17/2009EP2069500A2 Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof
06/17/2009EP2069499A2 Endophyte enhanced seedlings with increased pest tolerance
06/17/2009EP2069498A1 Inhibitory polynucleotide compositions and methods for treating cancer
06/17/2009EP2069497A2 Oligonucleotides for use in allele-specific pcr
06/17/2009EP2069495A1 Nucleic acid purification method
06/17/2009EP2069494A2 Cellulase-free enzyme compositions and host cells for producing the same
06/17/2009EP2069493A1 Methods and devices for the delivery of peptides into the gastric mucosa
06/17/2009EP2069490A2 Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them
06/17/2009EP2069489A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
06/17/2009EP2069398A2 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells
06/17/2009EP2069394A1 Identification of candidate vaccine antigens from dichelobacter nodosus
06/17/2009EP2069392A2 Tnf superfamily fusion proteins
06/17/2009EP2069389A2 Glucanases, nucleic acids encoding them and methods for making and using them
1 ... 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 ... 4023